You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 6, 2016

IP Lunch Talk: Tilleke & Gibbins and NIA to Hold Discussion on Healthcare Business

Tilleke & Gibbins and National Innovation Agency

The key drivers of healthcare product investment are the effective protection of intellectual property rights and compliance with the law. Protection of IP rights and obtaining market authorization are challenges faced by every company operating in the healthcare industry. To discuss these issues and more, Dr. Atthachai Homhuan, regulatory affairs manager at Tilleke & Gibbins, will present on “Intellectual Property and Regulatory Perspectives of Thailand’s Healthcare Business” at an IP Lunch Talk held by Tilleke & Gibbins and the National Innovation Agency. In particular, Atthachai will discuss the following issues:

  • IP rights and dealing with local distributors
  • Healthcare legislation and regulation in Thailand and ASEAN harmonization
  • Recent and upcoming changes to healthcare-related IP and laws/regulations in Thailand

This seminar will be held at Tilleke & Gibbins’ Bangkok office on May 26 from 11.30 a.m. to 1.30 p.m. Atthachai’s presentation will be followed by a Q&A session. If you would like to learn more about this event, please contact Pinta P. Macdougall at [email protected].

RELATED INSIGHTS​ 

May 29, 2012
The ASEAN Economic Community (AEC), which will come into effect in 2015, will integrate the region’s economies and create a single market of 600 million consumers. All industries are bracing for this change, but the competitive landscape is transforming even more quickly in the healthcare sector. Regional harmonization has already commenced for the cosmetics industry, while further integration is imminent for other industries and products, such as medical devices.
May 29, 2012
The Thai pharmaceutical industry is characterized by its expanding yet challenging landscape. Amidst growing medical tourism and strong R&D centers in the Asia Pacific region, issues related to patent protection, counterfeit drugs, and innovation recognition are increasingly imperative for pharmaceutical companies.
April 26, 2012
Three members of the Tilleke & Gibbins team have been named to The International Who’s Who of Life Sciences Lawyers 2012. Published by Law Business Research, the official research partner of the International Bar Association, this guide identifies 546 experts in 48 jurisdictions who are considered leaders in serving clients in the life sciences sector.The Tilleke & Gibbins attorneys recognized by the publication are: